Evaluate RCN3028 in Treatment of Drug-Induced VMS in Breast Cancer

Stopped Difficulty in recruiting breast cancer patients, leading to a slow rate of case enrollment.

Conditions

• Hot Flashes
• Breast Cancer

Interventions

• DRUG: 0.8 mg RCN3028
• DRUG: Placebo

Sponsor

Yung Shin Pharm. Ind. Co., Ltd.